DiaMedica anticipates ReMEDy2 interim analysis in Q1 2027 as enrollment surpasses 85% of 200-patient trigger
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
Namibia: N$178m Medical Store Project to Strengthen Medicine Supply
[New Era] The government is investing nearly N$178 million to expand Namibia's medical storage capacity as the Ministry of Health and Social Services continues efforts to address shortages of…
Infinimmune Raises $75M To Advance Human Antibody Pipeline
Infinimmune Raises $75M For Clinical Development Infinimmune has raised $75 million in Series A funding to advance its antibody therapeutics pipeline.
Ozempic Teeth, Muscle Loss: Some of the Buzziest GLP-1 Side Effects
(MedPage Today) -- GLP-1 drugs, used for type 2 diabetes and weight loss, have been touted for their many benefits, but it's their side effects that often make headlines, especially those with…
Somalia child hunger surges as aid drops, Doctors Without Borders says
Funding to tackle acute malnutrition in parts of Somalia has dropped by more than 80 per cent this year, Doctors Without Borders said on Tuesday, even though one in every four children screened in…
England Set To Eliminate Hepatitis C
An anonymous reader quotes a report from the BBC: England is on track to become one of the first countries in the world to eliminate hepatitis C, a dangerous virus that attacks the liver, figures…
Maternal vaping linked to SUDI cases involving bed sharing
Maternal vaping is emerging as a potential risk factor for sudden unexpected death in infancy (SUDI), according to New Zealand researchers who say their findings highlight the need to reassess public…